Acadia Healthcare Co. (NASDAQ:ACHC)’s share price shot up 3.8% on Thursday . The stock traded as high as $54.58 and last traded at $53.25, with a volume of 1,611,905 shares trading hands. The stock had previously closed at $51.29.

Several research firms have weighed in on ACHC. Zacks Investment Research upgraded shares of Acadia Healthcare from a “hold” rating to a “buy” rating and set a $71.00 target price for the company in a report on Monday, May 2nd. Jefferies Group reiterated a “buy” rating on shares of Acadia Healthcare in a report on Sunday, July 17th. Leerink Swann reiterated a “buy” rating on shares of Acadia Healthcare in a report on Monday, May 2nd. Mizuho lifted their price target on shares of Acadia Healthcare from $66.00 to $71.00 and gave the stock a “buy” rating in a report on Friday, April 29th. Finally, Robert W. Baird reiterated a “buy” rating on shares of Acadia Healthcare in a report on Monday, May 16th. One research analyst has rated the stock with a sell rating, one has given a hold rating and ten have issued a buy rating to the stock. Acadia Healthcare currently has an average rating of “Buy” and a consensus target price of $79.33.

The firm has a market cap of $4.66 billion and a PE ratio of 31.68. The firm’s 50-day moving average price is $55.91 and its 200 day moving average price is $57.11.

Acadia Healthcare (NASDAQ:ACHC) last issued its earnings results on Thursday, April 28th. The company reported $0.55 EPS for the quarter, topping the consensus estimate of $0.54 by $0.01. During the same period last year, the business earned $0.43 earnings per share. The firm earned $616.80 million during the quarter, compared to the consensus estimate of $612.77 million. The firm’s revenue for the quarter was up 68.6% compared to the same quarter last year. Equities analysts predict that Acadia Healthcare Co. will post $2.82 EPS for the current year.

A number of hedge funds and institutional investors have recently modified their holdings of ACHC. US Bancorp DE boosted its position in shares of Acadia Healthcare by 29.1% in the fourth quarter. US Bancorp DE now owns 23,508 shares of the company’s stock valued at $1,469,000 after buying an additional 5,298 shares during the period. Trexquant Investment LP boosted its position in shares of Acadia Healthcare by 93.3% in the fourth quarter. Trexquant Investment LP now owns 27,300 shares of the company’s stock valued at $1,705,000 after buying an additional 13,176 shares during the period. Rhumbline Advisers boosted its position in shares of Acadia Healthcare by 6.1% in the fourth quarter. Rhumbline Advisers now owns 53,198 shares of the company’s stock valued at $3,323,000 after buying an additional 3,045 shares during the period. Mutual of America Capital Management LLC boosted its position in shares of Acadia Healthcare by 0.3% in the fourth quarter. Mutual of America Capital Management LLC now owns 57,344 shares of the company’s stock valued at $3,582,000 after buying an additional 194 shares during the period. Finally, California Public Employees Retirement System boosted its position in shares of Acadia Healthcare by 0.9% in the fourth quarter. California Public Employees Retirement System now owns 82,700 shares of the company’s stock valued at $5,165,000 after buying an additional 700 shares during the period.

Acadia Healthcare Company, Inc is a provider of behavioral healthcare services. The Company operates in two segments: U.S. Facilities and U.K. Facilities. The Company develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities and facilities providing outpatient behavioral healthcare services to serve the behavioral health and recovery needs of communities throughout the United States, the United Kingdom and Puerto Rico.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.